[English] 日本語

- PDB-1in2: Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 1in2 | ||||||
---|---|---|---|---|---|---|---|
Title | Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog | ||||||
![]() | IGFBP-1 antagonist | ||||||
![]() | ANTAGONIST / covalently constrained helix | ||||||
Function / homology | PENTANE![]() | ||||||
Method | SOLUTION NMR / restrained molecular dynamics | ||||||
![]() | Skelton, N.J. / Chen, Y.M. / Dubree, N. / Quan, C. / Jackson, D.Y. / Cochran, A.G. / Zobel, K. / Deshayes, K. / Baca, M. / Pisabarro, M.T. / Lowman, H.B. | ||||||
![]() | ![]() Title: Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1. Authors: Skelton, N.J. / Chen, Y.M. / Dubree, N. / Quan, C. / Jackson, D.Y. / Cochran, A. / Zobel, K. / Deshayes, K. / Baca, M. / Pisabarro, M.T. / Lowman, H.B. #1: ![]() Title: Molecular Mimics of Insulin-like Growth Factor 1 (IGF-1) for Inhibiting IGF-1: IGF-Binding Protein Interactions Authors: Lowman, H.B. / Chen, Y.M. / Skelton, N.J. / Mortensen, D.L. / Tomlinson, E.E. / Sadick, M.D. / Robinson, I.C. / Clark, R.G. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 92 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 63 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
Related structure data | ![]() 1gjeC ![]() 1gjfC ![]() 1gjgC ![]() 1imwC ![]() 1in3C C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
NMR ensembles |
|
-
Components
#1: Protein/peptide | Mass: 1642.879 Da / Num. of mol.: 1 / Source method: obtained synthetically Details: The peptide was chemically synthesized. It was designed from sequence selected from a phage display library. |
---|---|
#2: Chemical | ChemComp-LNK / |
Has protein modification | Y |
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMR experiment |
| ||||||||||||||||||||
NMR details | Text: This structure was determined using standard 2D homonuclear techniques. |
-
Sample preparation
Details |
| |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample conditions |
| |||||||||||||||
Crystal grow | *PLUS Method: other / Details: NMR |
-NMR measurement
NMR spectrometer | Type: Bruker AVANCE / Manufacturer: Bruker / Model: AVANCE / Field strength: 500 MHz |
---|
-
Processing
NMR software |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method: restrained molecular dynamics / Software ordinal: 1 Details: The structure was detemined on the basis of 138 NOE distance restraints and 11 dihedral angle restraints. The resulting ensemble had no restraint violations greater than 0.07 Angstroms or 1. ...Details: The structure was detemined on the basis of 138 NOE distance restraints and 11 dihedral angle restraints. The resulting ensemble had no restraint violations greater than 0.07 Angstroms or 1.4 deg. The mean restraint violation energy was 0.04 +/- 0.03 kcal/mol. | ||||||||||||||||
NMR representative | Selection criteria: fewest violations | ||||||||||||||||
NMR ensemble | Conformer selection criteria: structures with the least restraint violations Conformers calculated total number: 80 / Conformers submitted total number: 20 |